Letter to Senate re Immunocompromised Patients and COVID Funding
Citations
American Society of Hematology. (2022).
Letter to Senate re Immunocompromised Patients and COVID Funding.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/letter-to-senate-re-immunocompromised-patients-and-covid-funding.
American Society of Hematology.
"Letter to Senate re Immunocompromised Patients and COVID Funding." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/letter-to-senate-re-immunocompromised-patients-and-covid-funding
(label-accessed March 29, 2024).
"American Society of Hematology."
Letter to Senate re Immunocompromised Patients and COVID Funding, 29 Mar. 2024 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/letter-to-senate-re-immunocompromised-patients-and-covid-funding.